News

Video

ASCRS 2025: New research findings highlight the surprising impact of hyperosmolarity

Lisa Nijm, MD, says preoperative osmolarity testing can help clinicians manage patient expectations and improve surgical results.

Lisa Nijm, MD, joined the Eye Care Network at the American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting for an on-camera conversation. Dr. Nijm is the CEO of Warrenville EyeCare and LASIK in Warrenville, Illinois, and an assistant clinical professor of ophthalmology at the University of Illinois Eye and Ear Infirmary in Chicago, Illinois.

Dr. Nijm discussed her ASCRS presentation, focused on a study of hyperosmolarity's impact on cataract surgery outcomes. "Hyperosmolarity induces light scatter that's equivalent to a grade 2 to 3 cataract," Dr. Nijm said. "What that did show in the study is patients could [undergo] a perfect cataract surgery, pick the right lens...and still, patients would be dissatisfied with their vision afterwards, because they're experiencing this light scatter every time they're blinking. That distorts the image and decreases the quality of their vision"

Hyperosmolar patients were seven times more likely to be dissatisfied post-surgery, Dr. Nijm said, indicating that preoperative osmolarity testing is vital to a successful outcome. Preoperative testing could help clinicians manage patient expectations and improve surgical results, she said. The study results emphasized that it's crucial for surgeons to understand and, where possible, manage osmolarity to enhance refractive outcomes and patient satisfaction in cataract surgery.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
Alex Hacopian, MD, discusses a presbyopia-correcting IOL at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
© 2025 MJH Life Sciences

All rights reserved.